Collin, N;Guérin, JL;Drexler, I;Blanié, S;Gelfi, J;Boullier, S;Foucras, G;Sutter, G;Messud-Petit, F
The poxviral scrapin MV-LAP requires a myxoma viral infection context to efficiently downregulate MHC-I molecules.
Virology
2005
343
2
171-8

Paschen, A;Jing, W;Drexler, I;Klemm, M;Song, M;Müller-Berghaus, J;Nguyen, XD;Osen, W;Stevanovic, S;Sutter, G;Schadendorf, D
Melanoma patients respond to a new HLA-A*01-presented antigenic ligand derived from a multi-epitope region of melanoma antigen TRP-2.
Int J Cancer
2005
116
6
944-8

Quinnan, GV;Yu, XF;Lewis, MG;Zhang, PF;Sutter, G;Silvera, P;Dong, M;Choudhary, A;Sarkis, PT;Bouma, P;Zhang, Z;Montefiori, DC;Vancott, TC;Broder, CC
Protection of rhesus monkeys against infection with minimally pathogenic simian-human immunodeficiency virus: correlations with neutralizing antibodies and cytotoxic T cells.
J Virol
2005
79
6
3358-69

Erfle, V;Goebel, FD;Guzman, CA;Le Grand, R
Vaccines based on Nef and on Nef/DeltaV2 Env.
Microbes Infect
2005
7
14
1400-4

Staib, C;Kisling, S;Erfle, V;Sutter, G
Inactivation of the viral interleukin 1beta receptor improves CD8+ T-cell memory responses elicited upon immunization with modified vaccinia virus Ankara.
J Gen Virol
2005
86
Pt 7
1997-2006

Kramer-Hämmerle, S;Ceccherini-Silberstein, F;Bickel, C;Wolff, H;Vincendeau, M;Werner, T;Erfle, V;Brack-Werner, R
Identification of a novel Rev-interacting cellular protein.
BMC Cell Biol
2005
6
1
20

Greenwood, AD;Stengel, A;Erfle, V;Seifarth, W;Leib-Mösch, C
The distribution of pol containing human endogenous retroviruses in non-human primates.
Virology
2005
334
2
203-13

Hoffmann, D;Buchberger, B;Nemetz, C
In vitro synthesis of enzymatically active HIV-1 protease for rapid phenotypic resistance profiling.
J Clin Virol
2005
32
4
294-9

Moore, RA;Vorberg, I;Priola, SA
Species barriers in prion diseases--brief review.
Arch Virol Suppl
2005
19
187-202

Jew, S;Schätzl, HM
Prion: gene, structure, and species barrier.
J Am Osteopath Assoc
2005
105
1
23